SCHEMBL8806809

SCHEMBL8806809

CC(=O)OC1CCN(c2ccc3c(c2Br)CCC(=O)N3)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN1A P35498 1/20 0.35
▸ SCN5A Q14524 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ CRBN Q96SW2 2/20 0.34
▸ TRPV1 Q8NER1 2/20 0.34
▸ SLC6A4 P31645 3/20 0.34
▸ HTR1A P08908 2/20 0.34
▸ HTR1D P28221 2/20 0.34
▸ HTR1B P28222 2/20 0.34
▸ KCNH2 Q12809 2/20 0.34
▸ DRD2 P14416 6/20 0.33
▸ ADRA1D P25100 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ ADRA1B P35368 1/20 0.33
▸ DRD4 P21917 4/20 0.32
▸ DRD3 P35462 4/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8806234 0.82 HSP90AA1 (0.37) SCN1ASCN5ASCN9ACRBNTRPV1
SCHEMBL8805021 0.78 CRBN (0.39) CRBNTRPV1SLC6A4KCNH2DRD2
SCHEMBL8805370 0.75 SLC6A4 (0.53) CRBNSLC6A4HTR1AKCNH2DRD2
SCHEMBL29096730 0.68 DDB1 (0.50) CRBNHRH3USP2MAPTDDB1
SCHEMBL8805917 0.68 DRD2 (0.37) SCN1ASCN5ASCN9ASLC6A4HTR1A
SCHEMBL578125 0.66 ALDH1A1 (0.46) HRH3USP2LMNAMAPT
SCHEMBL16110909 0.65 NPC1 (0.39) CRBNSLC6A4HTR1AHTR1DHTR1B
SCHEMBL8806639 0.64 ALDH1A1 (0.43) SLC6A4HTR1AHTR1DHTR1BKCNH2
SCHEMBL9409028 0.64 MAPT (0.41) USP2MAPTTSHRHTT
SCHEMBL29772094 0.63 MAPT (0.48) ALOX15HSD17B10LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0583136-B1 Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders KISSEI PHARMACEUTICAL (JP) 1997-10-08 — — EP disclosed
US-5294718-A Platelet aggregation inhibitors; antiischemic agents; side effect reduction KISSEI PHARMACEUTICAL CO., LTD. (JP) 1994-03-15 — — US disclosed
EP-0583136-A2 Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders Kissei Pharmaceutical Co., Ltd. (JP) 1994-02-16 — — EP disclosed
Send feedback